ICICI Prudential US Bluechip Equity Fund - IDCW - Regular Plan

  • Previous Nav

  • Net Change on 22-09-2023

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview IDCW | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of ICICI Prudential US Bluechip Equity Fund is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities of companies listed on recognized stock exchanges in the United States of America. The Scheme shall also invest in ADRs/GDRs issued by Indian and foreign companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
ICICI Prudential US Bluechip Equity Fund - IDCW -21.54 -8.39 26.70 14.81 12.79 15.52
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P 500 -1.54 -1.41 14.96 9.22 8.07 7.70

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
ICICI Prudential US Bluechip Equity Fund - IDCW Jul 06, 2012 26.70 14.81 12.79 2.02 2,828.27
NIPPON INDIA - US EQUITY OPPORTUNITES FUND - IDCW Option Jul 23, 2015 19.15 9.35 10.37 2.41 601.94
NIPPON INDIA - JAPAN EQUITY FUND - IDCW Option Aug 26, 2014 19.99 3.24 3.39 2.44 295.01
Franklin Asian Equity Fund - IDCW Jan 16, 2008 3.82 -2.52 1.31 2.51 273.81
Aditya Birla Sun Life International Equity Fund - Regular - IDCW Nov 15, 2007 9.62 7.02 5.26 2.50 205.58

Fund Holdings as on 31-August-2023

  • Veeva Systems Inc

  • Alphabet Inc

  • TRANSUNION

  • Tyler Technologies Inc

  • Walt Disney

  • Zimmer Biomet Holdings Inc

  • Equifax Inc.

  • Salesforce.Com Inc

  • Comcast Corporation

  • Medtronic Plc

  • Intercontinental Exchange

  • ECOLAB INC

  • Emerson Electric

  • Masco Corp.

  • Allegion plc

  • Domino's Pizza Inc

  • TERADYNE INC

  • 3M Co

  • Biogen Inc

  • Kellogg Co.

  • ETSY INC

  • Pfizer Inc

  • US Bancorp Inc

  • Polaris Industries Inc.

  • Wells Fargo & Co

  • Gilead Sciences Inc

  • International Flavors & Fragrances Inc

  • TREPS

  • ServiceNow Inc.

  • Facebook Inc

  • Adobe Inc

  • Amazon com

  • Workday Inc

  • Estee Lauder Cos Inc

  • Corteva Inc

  • Fortinet INC

  • MarketAxess Holdings Inc

  • Agilent Technologies Co Ltd

  • Microsoft Corp

  • Bank of New York Mellon (US)

  • Blackrock (US)

  • Lam Research Corporation

  • Nike Inc

  • Constellation Brands Inc

  • Water Corp

  • Amgen Inc

  • Roper Technologies Inc

  • Intuit Inc

  • Bank of America Corp

  • Guidewire Software Inc

  • Microchip Technology Inc.

  • Charles Schwab Corp

  • TRADEWEB MARKETS INC-CLASS A

  • Berkshire Hathway Inc. (US)

  • Keurig Dr Pepper Inc.

  • Cognizant Tech Solutions

  • Intel Corp

  • Taiwan Semiconductor Mfg. Co. Ltd.

  • Viatris Inc.

  • Net Current Assets

View More
  • Miscellaneous

View More

About ICICI Prudential US Bluechip Equity Fund

Scheme Analysis

ICICI Prudential US Bluechip Equity Fund is a Equity - Thematic Fund - Global fund and belongs to ICICI Prudential Mutual Fund. It was launched on 06-Jul-2012 and currently has an AUM of ₹2,828.27 crore. ICICI Prudential US Bluechip Equity Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P 500 as secondary index.

The NAV of ICICI Prudential US Bluechip Equity Fund ended down ₹-0.35(-0.69%)yesterday to ₹50.45.

Among its top 3 holdings the fund has exposure to Veeva Systems Inc, and

The ICICI Prudential US Bluechip Equity Fund is managed by Rohan Maru and Sharmila Dmello.

Fund House Contact

One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 2652 5000
enquiry@icicipruamc.com
+91 (22) 2652 8100